@article{10717,
  keywords = {Humans, Calcium Channel Blockers/adverse effects, Antihypertensive Agents/therapeutic use, Sodium Chloride Symporter Inhibitors/adverse effects, Cohort Studies, *Pancreatic Neoplasms/chemically induced/epidemiology/complications, *Dihydropyridines/therapeutic use, *Hypertension/drug therapy/epidemiology/chemically induced, antihypertensive drugs, calcium channel blockers, Cancer, Cohort study, Pancreatic cancer, propensity score, Thiazide diuretics},
  author = {J. Rouette and E. McDonald and T. Schuster and J. Brophy and L. Azoulay},
  title = {Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study},
  year = {2022},
  journal = {J Am Heart Assoc},
  volume = {11},
  edition = {2022/12/15},
  number = {24},
  pages = {e026789},
  isbn = {2047-9980},
  doi = {10.1161/jaha.122.026789},
  note = {2047-9980
Rouette, Julie
Orcid: 0000-0003-3882-0998
McDonald, Emily G
Orcid: 0000-0003-0783-0624
Schuster, Tibor
Brophy, James M
Orcid: 0000-0001-8049-6875
Azoulay, Laurent
Orcid: 0000-0001-5162-3556
FDN‐143328/CIHR/Canada
Journal Article
Research Support, Non-U.S. Gov't
England
J Am Heart Assoc. 2022 Dec 20;11(24):e026789. doi: 10.1161/JAHA.122.026789. Epub 2022 Dec 14.},
  language = {eng},
}